Skip to content

Chlorpheniramine

Published: July 26, 2026Updated: August 27, 2026

Chlorpheniramine is a first-generation antihistamine medication that provides relief from allergic symptoms by blocking histamine receptors. It is commonly used to treat seasonal allergies, hay fever, allergic conjunctivitis, and allergic skin reactions like hives.

Quick summary

Chlorpheniramine is an antihistamine used to relieve allergy symptoms such as sneezing, itching, watery eyes, and runny nose.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ATC
R06AB04
RxNorm
2400
Generic
Chlorpheniramine
Class
atc-r06
Brands
Zodryl DAC, Zodryl AC, Tuzistra, Chlor-Trimeton, Tuxarin, Aller-Chlor, Ventuss, Clorrelief, Tannic-12 S, Tussionex, Poly Hist PD, Wal-finate
Availability
otc
Pregnancy
B
Lactation
caution
Half-life (h)
20
Onset (min)
30
Duration (h)
6
Routes
oral
Forms
tablet, extended-release tablet, chewable tablet, capsule, syrup, oral solution
Regions
United States, Canada, United Kingdom, Australia, European Union, India
Monitoring
none

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
4mg every 4-6 hours
Maximum
consult physician
Frequency
every 4-6 hours as needed
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
2mg every 4-6 hours
Maximum
consult physician
Frequency
every 4-6 hours as needed
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
2-4mg every 4-6 hours
Maximum
consult physician
Frequency
every 4-6 hours as needed
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious toxicity in adults
Chronic overdose: Cumulative daily doses exceeding 40-60 mg over extended periods may lead to chronic toxicity
Immediate actions
Supportive care, airway management, activated charcoal if within 1-2 hours of ingestion
Antidote
No specific antidote available(Treatment is supportive and symptomatic)
Poison Control: 1-800-222-1222

Special Populations

11 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use only if clearly needed and benefits outweigh potential risks

Monitor

regular prenatal care

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

use lowest effective dose

Key Recommendations

avoid prolonged use, use only when benefits outweigh risks

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

avoid near term

Key Recommendations

discontinue at least 2 weeks before delivery if possible

Monitor

fetal monitoring in late pregnancy

Use with caution and monitor for adverse effects.

⚠

lactation

breastfeeding
caution
FDA Category
N
Dose Adjustment

use lowest effective dose

Key Recommendations

avoid high doses or prolonged use, monitor infant for sedation or irritability

Monitor

observe infant for unusual drowsiness or irritability

Use with caution and monitor for adverse effects.

✗

pediatric_age

under 2 years
contraindicated
FDA Category
N
Dose Adjustment

not recommended

Key Recommendations

do not use in infants under 2 years due to risk of severe CNS depression

Monitor

emergency medical attention if used

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pediatric_age

2 to 12 years
caution
FDA Category
N
Dose Adjustment

weight-based dosing, do not exceed recommended maximum

Key Recommendations

use pediatric formulation, avoid adult formulations

Monitor

monitor for excessive sedation or paradoxical excitement

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

start with lowest dose, consider dose reduction

Key Recommendations

use with caution due to increased sensitivity to anticholinergic effects

Monitor

monitor for falls, confusion, urinary retention, constipation

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild
caution
FDA Category
N
Dose Adjustment

no significant dose adjustment needed

Key Recommendations

monitor renal function periodically

Monitor

periodic renal function monitoring

Use with caution and monitor for adverse effects.

⚠

renal_impairment

moderate to severe
caution
FDA Category
N
Dose Adjustment

reduce dose by 25-50%

Key Recommendations

use with caution, extended dosing intervals recommended

Monitor

regular monitoring of renal function and drug accumulation

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

consider dose reduction

Key Recommendations

use with caution, monitor for excessive sedation

Monitor

monitor liver function tests periodically

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

severe
caution
FDA Category
N
Dose Adjustment

significant dose reduction recommended

Key Recommendations

use only if benefits outweigh risks, avoid prolonged use

Monitor

close monitoring for sedation and adverse effects

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

Commonly prescribed since

Value:1950s

General prescribing information

drug_classWHO
2023

Drug class

Value:First-generation antihistamine

Drug class information

usageMedical guidelines
2023

Common uses

Value:Allergic rhinitis, hay fever, common cold symptoms, urticaria

Common therapeutic uses

mechanismFDA
2023

Mechanism of action

Value:H1 receptor antagonist (blocker)

Mechanism of action information

Treats allergic rhinitis, hay fever, allergic conjunctivitis, urticaria (hives), angioedema, and provides symptomatic relief from common cold symptoms including sneezing and rhinorrhea.

Acts as a competitive histamine H1 receptor antagonist, blocking the binding of histamine to these receptors and thereby reducing allergic response symptoms such as itching, swelling, and mucus production.

Causes drowsiness and sedation; avoid operating machinery. Has anticholinergic effects (dry mouth, blurred vision, constipation). Use with caution in elderly patients, those with narrow-angle glaucoma, or urinary retention. Alcohol and CNS depressants may enhance sedation. Available over-the-counter and as prescription formulations.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy